Cargando…
A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data
SIMPLE SUMMARY: Prostate cancer is one of the leading causes of cancer-related death in men in the world, but a large proportion of men that are diagnosed with prostate cancer do not have a form of the disease that will cause them long term harm. Therefore, there is a need to accurately predict the...
Autores principales: | O’Connell, Shea P., Frantzi, Maria, Latosinska, Agnieszka, Webb, Martyn, Mullen, William, Pejchinovski, Martin, Salji, Mark, Mischak, Harald, Cooper, Colin S., Clark, Jeremy, Brewer, Daniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027643/ https://www.ncbi.nlm.nih.gov/pubmed/35454901 http://dx.doi.org/10.3390/cancers14081995 |
Ejemplares similares
-
Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018) -
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2020) -
CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2019) -
Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018) -
Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)